Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...

July 19, 2024 | Friday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Valneva's Single-Dose Chikungunya Vaccine, IXCHIQ®, Receives European Commission Approval

  Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...

July 01, 2024 | Monday | News
Moderna’s mRESVIA Receives Positive CHMP Opinion for RSV Vaccine in Adults 60+

Moderna,  announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

July 01, 2024 | Monday | News
Regulatory Review Begins for Bavarian Nordic's Single-Dose Chikungunya Vaccine in EU and U.S.

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...

June 26, 2024 | Wednesday | News
Phase I Clinical Trial Begins for AstriVax's Novel Vaccines

The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with A...

June 24, 2024 | Monday | News
WACKER and CordenPharma Consortium Enters Pandemic Readiness State to Produce 80 Million Vaccine Doses Annually

    • Consortium formed between WACKER & CordenPharma has officially entered the pandemic readiness state as of 1 June 2024 to produ...

June 21, 2024 | Friday | News
Moderna's Next-Gen COVID-19 Vaccine mRNA-1283 Excels in Phase 3 Trial

Moderna, announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint, demon...

June 17, 2024 | Monday | News
Integrated DNA Technologies Unveils Avian Influenza A (H5) Detection Kit Amid Rising H5N1 Concerns in Dairy Cows

Amidst growing concerns from U.S. federal, state and local agencies over Highly Pathogenic Avian Influenza (HPAI) A (H5N1) detections in dairy cows, Inte...

June 11, 2024 | Tuesday | News
BioNTech and CEPI Partner to Enhance mRNA Vaccine Production in Africa

BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, fo...

May 30, 2024 | Thursday | News
CancerVax, Inc. Achieves Precision Cancer Targeting Milestone with Nobel-Winning Chemistry

CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer,  announced that its UCLA res...

May 21, 2024 | Tuesday | News
Moderna's Investigational RSV Vaccine Review Delayed by FDA

Moderna, Inc. received notification from the U.S. Food and Drug Administration (FDA) regarding a delay in the review process for its investigational respir...

May 13, 2024 | Monday | News
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine

  Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...

May 10, 2024 | Friday | News
ArkeaBio™ Secures $26.5 Million Series A Funding to Develop Paradigm-Shifting Livestock Methane Reduction Vaccine

ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, announced the close of a $26.5 million Series A ...

May 09, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in